Crown ElectroKinetics Corp. (NASDAQ: CRKN) stock fell -6.16% on Monday to $0.25 against a previous-day closing price of $0.27. With 1.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.03 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $0.2748 whereas the lowest price it dropped to was $0.2451. The 52-week range on CRKN shows that it touched its highest point at $3.04 and its lowest point at $0.05 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRKN was down-trending over the past week, with a drop of -11.82%, but this was up by 59.00% over a month. Three-month performance dropped to -2.15% while six-month performance fell -70.07%. The stock lost -90.77% in the past year, while it has gained 34.46% so far this year. A look at the trailing 12-month EPS for CRKN yields -1.09 with Next year EPS estimates of -0.88.
Float and Shares Shorts:
At present, 17.64 million CRKN shares are outstanding with a float of 16.34 million shares on hand for trading. On Oct 13, 2022, short shares totaled 1.17 million, which was 6.65% higher than short shares on Sep 14, 2022. In addition to Mr. Douglas B. Croxall as the firm’s Chairman & CEO, Mr. Timothy Koch serves as its Co-Founder & CTO.
Through their ownership of 22.88% of CRKN’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 13.30% of CRKN, in contrast to 12.89% held by mutual funds. Shares owned by individuals account for 0.44%. As the largest shareholder in CRKN with 6.55% of the stake, Bard Associates, Inc. holds 1,327,000 shares worth 1,327,000. A second-largest stockholder of CRKN, Pitcairn Group LP, holds 417,180 shares, controlling over 2.06% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in CRKN, holding 173,237 shares or 0.86% stake. With a 0.36% stake in CRKN, the Fidelity Extended Market Index Fu is the largest stakeholder. A total of 72,292 shares are owned by the mutual fund manager. The Fidelity Series Total Market Inde, which owns about 0.05% of CRKN stock, is the second-largest Mutual Fund holder. It holds 10,703 shares valued at 2023.0. Fidelity Nasdaq Composite Index F holds 0.03% of the stake in CRKN, owning 5,276 shares worth 997.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRKN since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CRKN analysts setting a high price target of $1.50 and a low target of $1.50, the average target price over the next 12 months is $1.50. Based on these targets, CRKN could surge 500.0% to reach the target high and rise by 500.0% to reach the target low. Reaching the average price target will result in a growth of 500.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CRKN will report FY 2022 earnings on 03/26/2024. Analysts have provided yearly estimates in a range of -$0.91 being high and -$0.91 being low. For CRKN, this leads to a yearly average estimate of -$0.91. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Crown ElectroKinetics Corp. surprised analysts by $0.10 when it reported -$0.18 EPS against a consensus estimate of -$0.28. The surprise factor in the prior quarter was -$0.05. Based on analyst estimates, the high estimate for the next quarter is -$0.19 and the low estimate is -$0.19. The average estimate for the next quarter is thus -$0.19.
Summary of Insider Activity:
Insiders traded CRKN stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.